Literature DB >> 26507575

Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells.

Arthur W Lambert1, Chen Khuan Wong2, Sait Ozturk1, Panagiotis Papageorgis2, Rekha Raghunathan1, Yuriy Alekseyev3, Adam C Gower4, Björn M Reinhard5, Hamid M Abdolmaleky1, Sam Thiagalingam6.   

Abstract

UNLABELLED: Basal-like breast cancer (BLBC) is an aggressive subtype of breast cancer which is often enriched with cancer stem cells (CSC), but the underlying molecular basis for this connection remains elusive. We hypothesized that BLBC cells are able to establish a niche permissive to the maintenance of CSCs and found that tumor cell-derived periostin (POSTN), a component of the extracellular matrix, as well as a corresponding cognate receptor, integrin α(v)β(3), are highly expressed in a subset of BLBC cell lines as well as in CSC-enriched populations. Furthermore, we demonstrated that an intact periostin-integrin β3 signaling axis is required for the maintenance of breast CSCs. POSTN activates the ERK signaling pathway and regulates NF-κB-mediated transcription of key cytokines, namely IL6 and IL8, which in turn control downstream activation of STAT3. In summary, these findings suggest that BLBC cells have an innate ability to establish a microenvironmental niche supportive of CSCs. IMPLICATIONS: The findings reported here indicate that POSTN produced by CSCs acts to reinforce the stem cell state through the activation of integrin receptors and the production of key cytokines. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26507575      PMCID: PMC4715959          DOI: 10.1158/1541-7786.MCR-15-0079

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  55 in total

1.  Controversies in cancer stem cells: targeting embryonic signaling pathways.

Authors:  Naoko Takebe; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  Mammary development meets cancer genomics.

Authors:  Aleix Prat; Charles M Perou
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

3.  An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Kevin Struhl
Journal:  Cell       Date:  2009-10-29       Impact factor: 41.582

4.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Authors:  Chad J Creighton; Xiaoxian Li; Melissa Landis; J Michael Dixon; Veronique M Neumeister; Ashley Sjolund; David L Rimm; Helen Wong; Angel Rodriguez; Jason I Herschkowitz; Cheng Fan; Xiaomei Zhang; Xiaping He; Anne Pavlick; M Carolina Gutierrez; Lorna Renshaw; Alexey A Larionov; Dana Faratian; Susan G Hilsenbeck; Charles M Perou; Michael T Lewis; Jeffrey M Rosen; Jenny C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

5.  Smad signaling is required to maintain epigenetic silencing during breast cancer progression.

Authors:  Panagiotis Papageorgis; Arthur W Lambert; Sait Ozturk; Fangming Gao; Hongjie Pan; Upender Manne; Yuriy O Alekseyev; Arunthathi Thiagalingam; Hamid M Abdolmaleky; Marc Lenburg; Sam Thiagalingam
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

6.  CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

Authors:  Christophe Ginestier; Suling Liu; Mark E Diebel; Hasan Korkaya; Ming Luo; Marty Brown; Julien Wicinski; Olivier Cabaud; Emmanuelle Charafe-Jauffret; Daniel Birnbaum; Jun-Lin Guan; Gabriela Dontu; Max S Wicha
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

7.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

8.  Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Authors:  Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser
Journal:  Cell       Date:  2009-08-13       Impact factor: 41.582

9.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

Authors:  Emmanuelle Charafe-Jauffret; Christophe Ginestier; Flora Iovino; Julien Wicinski; Nathalie Cervera; Pascal Finetti; Min-Hee Hur; Mark E Diebel; Florence Monville; Julie Dutcher; Marty Brown; Patrice Viens; Luc Xerri; François Bertucci; Giorgio Stassi; Gabriela Dontu; Daniel Birnbaum; Max S Wicha
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

Review 10.  The multifaceted role of periostin in tumorigenesis.

Authors:  Kai Ruan; Shideng Bao; Gaoliang Ouyang
Journal:  Cell Mol Life Sci       Date:  2009-03-24       Impact factor: 9.261

View more
  23 in total

1.  MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer.

Authors:  Chen Khuan Wong; Christopher Gromisch; Sait Ozturk; Panagiotis Papageorgis; Hamid Mostafavi Abdolmaleky; Björn M Reinhard; Arunthathi Thiagalingam; Sam Thiagalingam
Journal:  Cancer Biol Ther       Date:  2019-03-28       Impact factor: 4.742

2.  Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Authors:  Raphaёl Kormann; Panagiotis Kavvadas; Sandrine Placier; Sophie Vandermeersch; Aude Dorison; Jean-Claude Dussaule; Christos E Chadjichristos; Niki Prakoura; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2019-11-05       Impact factor: 10.121

Review 3.  Periostin: an emerging activator of multiple signaling pathways.

Authors:  Zhaoheng Wang; Jiangdong An; Daxue Zhu; Haiwei Chen; Aixin Lin; Jihe Kang; Wenzhao Liu; Xuewen Kang
Journal:  J Cell Commun Signal       Date:  2022-04-12       Impact factor: 5.782

4.  Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.

Authors:  Li Jia; Guanhua Li; Na Ma; Aimin Zhang; Yunli Zhou; Li Ren; Dong Dong
Journal:  BMC Cancer       Date:  2022-07-12       Impact factor: 4.638

5.  Prognostic value of periostin in early-stage breast cancer treated with conserving surgery and radiotherapy.

Authors:  Changyou Li; Jing Xu; Qi Wang; Shaoqing Geng; Zheng Yan; Jin You; Zhenfeng Li; Xiao Zou
Journal:  Oncol Lett       Date:  2018-03-21       Impact factor: 2.967

Review 6.  The multifaceted role of periostin in priming the tumor microenvironments for tumor progression.

Authors:  Dan Cui; Zhengjie Huang; Yingfu Liu; Gaoliang Ouyang
Journal:  Cell Mol Life Sci       Date:  2017-09-07       Impact factor: 9.261

7.  POSTN Promotes the Proliferation of Spermatogonial Cells by Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Caihong Li; Dongkai Cheng; Peng Xu; Hongguang Nie; Tao Zhang; Xining Pang
Journal:  Reprod Sci       Date:  2021-05-06       Impact factor: 3.060

8.  Amelioration of Posttraumatic Osteoarthritis in Mice Using Intraarticular Silencing of Periostin via Nanoparticle-Based Small Interfering RNA.

Authors:  Xin Duan; Lei Cai; Christine T N Pham; Yousef Abu-Amer; Hua Pan; Robert H Brophy; Samuel A Wickline; Muhammad Farooq Rai
Journal:  Arthritis Rheumatol       Date:  2021-10-28       Impact factor: 15.483

Review 9.  Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model.

Authors:  Eric N Horst; Michael E Bregenzer; Pooja Mehta; Catherine S Snyder; Taylor Repetto; Yang Yang-Hartwich; Geeta Mehta
Journal:  Acta Biomater       Date:  2021-04-30       Impact factor: 10.633

10.  Epithelial Stem Cells: Making, Shaping and Breaking the Niche.

Authors:  Paula Ferraces-Riegas; Anona C Galbraith; David P Doupé
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.